Liesenfeld, Oliver
Inflammatix, Inc.,
United States
2025 Rank: 69502
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Microbiology
SubField 2:
Mycology & Parasitology
Rank in SubField 1: 1739 out of 217955 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 69502 | 68041 |
| Total Cites | 9823 | 11328 |
| H-index | 46 | 52 |
| Hm-index | 17 | 18 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 148 | 165 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 1266 | 1433 |
| Number of Single+First+Last Authored Papers | 69 | 69 |
| Total Cites to Single+First+Last Authored Papers | 5934 | 6505 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7620 | 8209 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.38 |
| Self-Citation Percentage |
13.29%
|
|
Liesenfeld, Oliver
Inflammatix Inc.,
United States
2024 Rank: 68277
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Microbiology
SubField 2:
Mycology & Parasitology
Rank in SubField 1: 1716 out of 204759 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 68277 | 68429 |
| Total Cites | 9107 | 10537 |
| H-index | 46 | 49 |
| Hm-index | 16 | 18 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 138 | 155 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 1220 | 1377 |
| Number of Single+First+Last Authored Papers | 69 | 69 |
| Total Cites to Single+First+Last Authored Papers | 5583 | 6133 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7057 | 7619 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.38 |
| Self-Citation Percentage |
13.57%
|
|
Liesenfeld, Oliver
Inflammatix, Inc.,
United States
2023 Rank: 67564
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Mycology & Parasitology
Rank in SubField 1: 1715 out of 190396 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 67564 | 65907 |
| Total Cites | 8511 | 9880 |
| H-index | 44 | 49 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 134 | 151 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 1181 | 1344 |
| Number of Single+First+Last Authored Papers | 68 | 68 |
| Total Cites to Single+First+Last Authored Papers | 5295 | 5841 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6575 | 7114 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.39 |
| Self-Citation Percentage |
13.86%
|
|
Liesenfeld, Oliver
Roche Molecular Diagnostics,
United States
2022 Rank: 65211
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Mycology & Parasitology
Rank in SubField 1: 1660 out of 175943 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 65211 | 64185 |
| Total Cites | 7789 | 9056 |
| H-index | 42 | 48 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 127 | 144 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 1126 | 1284 |
| Number of Single+First+Last Authored Papers | 67 | 67 |
| Total Cites to Single+First+Last Authored Papers | 4890 | 5411 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6002 | 6510 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.39 |
| Self-Citation Percentage |
13.99%
|
|
Liesenfeld, Oliver
Inflammatix,
United States
2021 Rank: 65826
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Mycology & Parasitology
Rank in SubField 1: 1679 out of 165244 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 65826 | 64709 |
| Total Cites | 7402 | 8622 |
| H-index | 41 | 46 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 119 | 136 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 1092 | 1242 |
| Number of Single+First+Last Authored Papers | 67 | 67 |
| Total Cites to Single+First+Last Authored Papers | 4645 | 5153 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5706 | 6197 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.39 |
| Self-Citation Percentage |
14.15%
|
|
Liesenfeld, Oliver
Inflammatix, Inc,
United States
2020 Rank: 65557
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Mycology & Parasitology
Rank in SubField 1: 1667 out of 134369 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 65557 | 63631 |
| Total Cites | 6555 | 7682 |
| H-index | 39 | 44 |
| Hm-index | 14 | 16 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 112 | 129 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 1040 | 1190 |
| Number of Single+First+Last Authored Papers | 67 | 67 |
| Total Cites to Single+First+Last Authored Papers | 4157 | 4637 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5064 | 5511 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.39 |
| Self-Citation Percentage |
14.67%
|
|
Related Profiles
.jpg)
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.